Viewing Study NCT00986258

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:05 AM
Ignite Modification Date: 2026-05-14 @ 9:08 PM
Study NCT ID: NCT00986258
Status: TERMINATED
Last Update Posted: 2019-01-09
First Post: 2009-09-28
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability
Sponsor: Grünenthal GmbH
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
None Chronic Pain View
None Low Back Pain View
None Neuropathic Pain View
None Nociceptive Pain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None pain assessment View
None tapentadol View
None centrally acting analgesic View